In this edition:
– Cryoablation vs drug therapy for paroxysmal AF
– Myopericarditis after COVID-19 mRNA vaccination
– Rate of progression of aortic stenosis
– Metformin can be safely used in patients exposed to contrast media
– Use of bempedoic acid in statin-intolerant patients
– Effects of dapagliflozin in heart failure patients with or without gout
– SGLT2 inhibitors and cancer outcomes
– Overweight or obesity increases the risk of cardiovascular disease
– Efficacy and safety of the oral PCSK9 inhibitor MK-0616
– Inflammation and cholesterol as predictors of cardiovascular events in patients taking statins
Download Cardiology Research Review, Issue 152, with commentary by A/Prof John Amerena (pdf)

